ELLIPTA dry powder versus metered-dose inhalers in an optimized clinical trial setting

ConclusionInhaler technique can be optimized in trial settings. In such settings, ELLIPTA is associated with higher rates of correct use and lower error rates than MDIs.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research